When we stratified patients by median fold changes of YTHDF1 expression, we found that increased YTHDF1 expression in DCs was associated with poor progression-free survival in these patients with NSCLC (P = 0.0188, Figure 1B). This evidence concerns the gene YTHDF1 and non-small cell lung carcinoma.